Archives for July 9, 2007

← 2007

Noven acquires JDS to transform business outlook

By  Dr Matt Wilkinson

Transdermal drug delivery expert Noven Pharmaceuticals is to buy JDS Pharmaceuticals in a deal worth $125m (€91m) to transform itself into a 'fully-integrated speciality pharmaceutical company'.

Outsourcing-Pharma.com special focus

Charting the course of Inyx' downfall

By  Kirsty Barnes

With a knife-edge financial history of spiralling debts, exacerbated by continued borrowing, Inyx' recent insolvency problems are hardly surprising.

Outsourcing-Pharma.com special focus

Legal wrangling as Inyx units are deemed insolvent

By  Kirsty Barnes

Almost the entire international operations of specialty pharma contract manufacturer Inyx is facing insolvency and the company is locked in a legal battle with its principal financier.

Shasun gets the thumbs up

By  Katrina Megget

Indian pharmaceutical manufacturing company Shasun Chemicals and Drugs has now got its eye fully on the US market after recent approval of its new formulation facility in Puducherry.

Citric acid sensor is faster and cheaper

By  George Reynolds

A new fluorescent chemical sensor can detect citric acid at low concentrations more rapidly and cheaply than current optical sensors, its developer claims.

Covance new animal-testing plant still drawing controversy

By  Emilie Reymond

Covance is again at the centre of controversy as opponents of the contract research organisation (CRO) filed a lawsuit against a city in Arizona, aimed at stopping the firm from building a new drug-testing facility there.

Anticalins look promising

By  Katrina Megget

A new generation of therapeutic protein products has entered the biopharma scene and are proving more efficient than antibodies when using the same drug delivery systems.